Effect of transferrin on hypomyelination induced by iron deficiency

J Neurosci Res. 2008 Sep;86(12):2663-73. doi: 10.1002/jnr.21709.

Abstract

We have used a model of iron deficiency in the rat to analyze the effects of a disruption in iron availability on oligodendroglial cell (OLGc) maturation and myelinogenesis and to explore the possible beneficial influence of an intracranial injection (ICI) of apotransferrin (aTf) at 3 days of age on this process. Studies carried out on postnatal days 17 and 24 showed that iron deficiency produced a decrease in myelin proteins and lipids at 24 days of age. Immunohistochemistry showed that in untreated iron-deficient (ID) rats, the immunoreactivity of anti-adenomatous polyposis coli (APC) and anti-MBP antibodies decreased markedly with reference to normal controls, whereas in ID rats treated with an ICI of aTf, the immunoreactivity of these markers increased. A similar situation occurred with the immunoreactivity of H-ferritin. In primary OLGc cultures from ID rats, there was a high number of cells positive to the antibody against the polysialylated form of the cell surface glycoprotein NCAM (PSA-NCAM) compared with in OLGc cultures prepared from normal controls or from ID animals treated with aTf. The number of MBP+ cells in cultures from ID rats increased after treatment with aTf. The presence of lipid rafts evaluated with a specific anti-protein prion cellular (PrPc) antibody showed a smaller number of PrPc-positive structures in ID rat cultures. Treatment of the ID animals with a single ICI of aTf stimulated myelination, producing a significant correction in the different biochemical parameters affected by ID.

Publication types

  • Comparative Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Anemia, Iron-Deficiency / blood
  • Anemia, Iron-Deficiency / drug therapy*
  • Anemia, Iron-Deficiency / pathology*
  • Animals
  • Animals, Newborn
  • Apoproteins / pharmacology
  • Apoproteins / therapeutic use*
  • Cells, Cultured
  • Demyelinating Diseases / blood
  • Demyelinating Diseases / drug therapy*
  • Demyelinating Diseases / pathology*
  • Disease Models, Animal
  • Female
  • Myelin Sheath / drug effects
  • Myelin Sheath / pathology
  • Nerve Fibers, Myelinated / drug effects
  • Nerve Fibers, Myelinated / pathology*
  • Pregnancy
  • Rats
  • Rats, Wistar
  • Transferrin / pharmacology
  • Transferrin / therapeutic use*

Substances

  • Apoproteins
  • Transferrin
  • apotransferrin